Drugs / Antithrombin concentrate (ATIIIC)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07285460 Background | Dec 2025 → Aug 2029 expected | hemophilia | Sanofi | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antithrombin concentrate (ATIIIC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07285460 ↗ |
| Route | Intravenous | “Route of administration: intravenous injection” NCT07285460 ↗ |